Toxicity, response, and survival in older adults with metastatic melanoma treated with checkpoint inhibitors.

Nienke A. de Glas,Esther Bastiaannet,Frederiek van den Bos,Simon P. Mooijaart,Astrid Aplonia Maria Van Der Veldt,Karijn P.M. Suijkerbuijk,Maureen J.B. Aarts,Franchette W.P.J. van den Berkmortel,Christian U. Blank,Marye Boers-Sonderen,Alfonsus J. M. van den Eertwegh,Jan Willem B. de Groot,Geke A.P. Hospers,John B. A. G. Haanen,Djura Piersma,Rozemarijn S. van Rijn,A. J. Ten Tije,Michel W.J.M. Wouters,Johanna E.A. Portielje,Ellen Kapiteijn

Toxicity, response, and survival in older adults with metastatic melanoma treated with checkpoint inhibitors.

2021

9544Background: Checkpoint inhibitors have strongly improved survival of patients with metastatic melanoma. Trials suggest no differences in outcomes between older and younger patients, but only re...

Keywords:

Cancer research
metastatic melanoma
Medicine
immune checkpoint inhibitors
Toxicity

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations